Log in

A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the effect of selenium (Se) in the prevention of human primary liver cancer. Three intervention trials were conducted among the residents at high risk to primary liver cancer (PLC) in Qidong county, Jiang-su province, the People’s Republic of China. This area has the second highest rate of PLC in China. One trial was undertaken among the general population in a township with supplement of table salt fortified with 15 ppm anhydrous sodium selenite (Se-salt) for 5 y and the other four townships with similar PLC incidence rate served as the controls using normal table salt. The second trial was undertaken among hepatitis B virus surface antigen carriers (HBVsAg+) receiving supplement of 200 μg Se in form of selenized, yeast (Se-yeast) daily vs placebo for 4 y. The third trial was carried out in members of families with high PLC incidence using Se-yeast (200 μg of Se daily) vs placebo for 2 y. The results showed that nutritional supplement of Se could reduce the PLC incidence significantly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. Y. Yu, Y. J. Zhu, and W. G. Li,Biol. Trace Element Res. 15, 231 (1988).

    Article  CAS  Google Scholar 

  2. WHO Expert Committee on Passive Immunization against Hepatitis B. p. 204 (1977).

  3. J. H. Watkinson,Anal. Chem. 38, 92 (1966).

    Article  PubMed  CAS  Google Scholar 

  4. Y. Cai, L. Lao, Y. Eai, and E. Shen,Tumor 6, 200 (1986) (in Chinese).

    Google Scholar 

  5. H. F. Stich, W. Stich, H. Rosin and M. O. Vallejera,Int. J. Cancer,34, 745 (1984).

    Article  PubMed  CAS  Google Scholar 

  6. G. N. Schrauzer,Advances in Nutr. Res. 2, 219 (1979).

    CAS  Google Scholar 

  7. S. Y. Yu, P. Ao, L. M. Wang, S. L. Huang, H. C. Chen, X. P. Lu, and Q. Y. Liu.Biol. Trace Element Res. 15, 243 (1988).

    Article  CAS  Google Scholar 

  8. X. P. Lu, S. D. Liao and S. Y. Yu,Chinese Biochem. J. 5, 235 (1989).

    CAS  Google Scholar 

  9. S. Y. Yu, X. P. Lu, and S. D. Liao,Metal Ions in Biology and Medicine, P. Collery, L. A. Poirier, M. Manfait and J. C. Etienne, eds. John Libbey Eurotext, Paris (1990) p. 487.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, SY., Ya-Jun-Zhu, Li, WG. et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29, 289–294 (1991). https://doi.org/10.1007/BF03032685

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032685

Index Entries

Navigation